Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Bone Density × Clear all

NCT06129851 2023-11-13

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

Phase 2 Not yet recruiting

Prostatic Neoplasms